Free Trial

Seer (SEER) Competitors

Seer logo
$2.11 +0.06 (+2.93%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SEER vs. CTKB, LAB, SENS, FEIM, QSI, MASS, QTRX, KEQU, OWLT, and RPID

Should you be buying Seer stock or one of its competitors? The main competitors of Seer include Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), Quantum-Si (QSI), 908 Devices (MASS), Quanterix (QTRX), Kewaunee Scientific (KEQU), Owlet (OWLT), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry.

Seer vs. Its Competitors

Cytek Biosciences (NASDAQ:CTKB) and Seer (NASDAQ:SEER) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Cytek Biosciences currently has a consensus price target of $5.60, indicating a potential upside of 34.13%. Given Cytek Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Cytek Biosciences is more favorable than Seer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Seer
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cytek Biosciences has a net margin of -3.27% compared to Seer's net margin of -506.15%. Cytek Biosciences' return on equity of -1.66% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Cytek Biosciences-3.27% -1.66% -1.30%
Seer -506.15%-25.10%-22.48%

Cytek Biosciences has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Seer has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 75.2% of Seer shares are owned by institutional investors. 10.3% of Cytek Biosciences shares are owned by company insiders. Comparatively, 11.3% of Seer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cytek Biosciences has higher revenue and earnings than Seer. Cytek Biosciences is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytek Biosciences$200.45M2.65-$6.02M-$0.05-83.50
Seer$14.17M8.39-$86.60M-$1.39-1.52

In the previous week, Seer had 6 more articles in the media than Cytek Biosciences. MarketBeat recorded 7 mentions for Seer and 1 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 1.22 beat Seer's score of -0.21 indicating that Cytek Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cytek Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Seer
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Cytek Biosciences beats Seer on 10 of the 16 factors compared between the two stocks.

Get Seer News Delivered to You Automatically

Sign up to receive the latest news and ratings for SEER and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEER vs. The Competition

MetricSeerMED IndustryMedical SectorNASDAQ Exchange
Market Cap$118.88M$3.09B$5.82B$9.75B
Dividend YieldN/A2.23%3.84%4.09%
P/E Ratio-1.5221.0131.1425.96
Price / Sales8.39396.98475.48122.90
Price / CashN/A43.0937.1558.38
Price / Book0.418.069.116.38
Net Income-$86.60M-$54.72M$3.26B$265.56M
7 Day Performance1.93%2.30%1.94%1.81%
1 Month Performance-1.86%7.21%4.91%1.14%
1 Year Performance30.25%12.85%31.21%20.98%

Seer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEER
Seer
0.5401 of 5 stars
$2.11
+2.9%
N/A+24.2%$118.88M$14.17M-1.52160
CTKB
Cytek Biosciences
3.5248 of 5 stars
$3.79
-6.0%
$5.60
+47.8%
-25.5%$512.71M$200.45M-75.80500Positive News
LAB
Standard BioTools
2.5558 of 5 stars
$1.28
-2.3%
$2.50
+96.1%
-38.1%$495.67M$174.43M-3.64620Gap Up
SENS
Senseonics
2.4156 of 5 stars
$0.47
-5.9%
$1.55
+232.3%
+6.2%$305.13M$25.47M-3.5990News Coverage
Positive News
FEIM
Frequency Electronics
1.3238 of 5 stars
$29.17
-1.2%
N/A+110.5%$287.27M$69.81M11.81200
QSI
Quantum-Si
2.2846 of 5 stars
$1.20
-5.5%
$3.48
+189.6%
+9.9%$233.04M$3.06M-1.76150
MASS
908 Devices
3.4662 of 5 stars
$6.43
+1.6%
$8.00
+24.4%
+42.7%$227M$59.63M-11.9160
QTRX
Quanterix
2.4013 of 5 stars
$4.58
-3.6%
$11.75
+156.6%
-63.2%$220.71M$137.42M-2.52460Positive News
KEQU
Kewaunee Scientific
2.2399 of 5 stars
$54.97
+3.7%
N/A+7.7%$156.19M$240.47M14.351,239Positive News
Short Interest ↓
OWLT
Owlet
3.3236 of 5 stars
$8.91
-4.2%
$10.25
+15.1%
+65.0%$153.68M$78.10M-2.54106Gap Up
RPID
Rapid Micro Biosystems
3.9515 of 5 stars
$3.26
-4.1%
$8.00
+145.4%
+219.1%$149.03M$28.05M-3.17200Positive News

Related Companies and Tools


This page (NASDAQ:SEER) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners